KSHV-encoded vIRF3 Cooperates with Cellular IRF4 to Drive Super-Enhancer Activity through Complex DNA Elements
Authors:
- Ziyan LiangZLZiyan Liang
- Haocong Katherine MaHMHaocong Katherine Ma
- Christine B. MagdongonCMChristine B. Magdongon
- Maureen E. HaynesMHMaureen E. Haynes
- Jingyi LuJLJingyi Lu
- Elizabeth T. BartomEBElizabeth T. Bartom
- Eva GottweinEGEva Gottwein
Preprint
Abstract
The Kaposi’s sarcoma-associated herpesvirus (KSHV) oncoprotein vIRF3 is essential for the survival of primary effusion lymphoma (PEL) cells. vIRF3 cooperates with cellular IRF4 to activate super-enhancers (SEs) driving oncogenes including MYC and IRF4 itself. However, the vIRF3/IRF4-responsive DNA sequences underlying this cooperation are unknown. Investigating the IRF4-SE, we mapped its vIRF3/IRF4-responsiveness to a complex ∼83 bp region, which retained cooperative activation by vIRF3 and IRF4 and was activated by vIRF3 but not IRF4 alone. vIRF3-mediated activation depended on an AP1 site, while the cooperation of vIRF3 with IRF4 required the DNA binding ability of IRF4 and IRF-related motifs that do not participate in canonical AP1-IRF (AICE) composite sites. These motifs are necessary but insufficient to confer responsiveness outside their native sequence context, suggesting that vIRF3/IRF4-mediated IRF4-SE activation requires an extended composite element. DNA pulldowns confirmed the importance of the identified motifs for association of vIRF3 and IRF4 with the IRF4-SE. A PEL MYC-SE similarly depended on an extended responsive element containing a critical AP1 site, within a functional AICE motif. Together, our results show that vIRF3 activates oncogenic SEs by co-opting complex genetic elements that may accommodate previously unknown IRF4 binding configurations, improving our understanding of vIRF3 and IRF4-dependent oncogenesis. GraphicalKeywords
This publication has 46 references indexed in Scilit:
- Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/LymphomaCancer Cell, 2018
- CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency FactorsCell Host & Microbe, 2017
- Super-Enhancers in the Control of Cell Identity and DiseaseCell, 2013
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-EnhancersCell, 2013
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity GenesCell, 2013
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell LymphomaCancer Cell, 2012
- MYC on the Path to CancerCell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Enzymatic Assembly of Overlapping DNA Fragments2011
- Graded Expression of Interferon Regulatory Factor-4 Coordinates Isotype Switching with Plasma Cell DifferentiationImmunity, 2006